NovoCure Ltd — Director's Dealing 2019

Aug 2, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-07-31

Reporting Person: Shah Pritesh (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-07-31	Ordinary Shares	M	5115	$34.00	Acquired	82091	Direct
2019-07-31	Ordinary Shares	S	5115	$82.92	Disposed	76976	Direct
2019-07-31	Ordinary Shares	M	3718	$83.30	Acquired	80694	Direct
2019-08-01	Ordinary Shares	S	1905	$83.203	Disposed	78789	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-07-31	Options to buy Ordinary Shares	$34.00	M	5115	Disposed	2028-07-30	Ordinary Shares (5115)	Direct
2019-07-31	Restricted Stock Units	$0.00	M	3718	Disposed		Ordinary Shares (3718)	Direct

Footnotes

F1: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah.

F2: Fully vested as of the date hereof.